Tracks : 18 Tuesday: The impact of smoking to Otologic Surgery outcome Authors: J.

The therapeutic potential of all clinical activities for the Phase I trial with Neu2000KL for treatment of acute brain injury.

The Phase I study as a three-part study was conducted to evaluate the safety of Neu2000KL judge on target in in 64 volunteers in, with maximum deliverable doses 16 young volunteers. and at target doses in 15 elderly subjects aged over 65 The results showed that Neu2000KL be administered safely and in doses of up sixth more than progress progress in Phase II trials for both ischemic stroke and sudden cardiac arrest at clinically relevant doses well tolerated.Tracks : 18 Tuesday: The impact of smoking to Otologic Surgery outcome Authors: J. Matthew Conoyer disc, David Kaylie, Bryan M. Marc Logan Bennett, C. Gary Jackson, MD Date September, 02 to 08.10 Clock Clock.